Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?/Experiment 1/Signature 1
Source: Figure 3A-F
Description: Nasopaheryngeal microbiome composition in COVID-19 patients and Control group. The graphs show the percentage of relative abundance (%) of the all taxonomic levels from Phylum to Species, obtained by using the MicrobAT Suite - SmartSeq. Each column in the plot represents a group, and each color in the column represents the relative abundance (%) for each taxon. In panel (A) we show the phyla with average relative abundance greater than 1% in all studied groups; we found two phyla significantly less abundant in COVID-19 patients respect to Controls, Proteobacteria, and Fusobacteria. Not statistically significant difference in taxa abundance was observed when T0 and T1 COVID-19 patients were compared. The other panels (B–F) show the taxa abundance from class to up species level significantly different between groups by Kruskal Wallis test. (B) class (C) order, (D) family, (E) genus (F) species. *p < 0.05; **p < 0.001.
Abundance in Group 1: decreased abundance in COVID-19 positive patients
| NCBI | Quality Control | Links |
|---|---|---|
| Fusobacteriaceae | ||
| Fusobacteriales | ||
| Fusobacteriota | ||
| Fusobacterium | ||
| Gammaproteobacteria | ||
| Haemophilus | ||
| Leptotrichia | ||
| Leptotrichiaceae | ||
| Pasteurellaceae | ||
| Pasteurellales |
Revision editor(s): Claregrieve1, Peace Sandy
